← Product Code [JIT](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIT) · K033860

# AUTOKIT TOTAL KETONE BODIES KIT (SERUM) AND WAKO KETONE BODY CALIBRATOR (K033860)

_Wako Chemicals USA, Inc. · JIT · Apr 23, 2004 · Clinical Chemistry · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIT/K033860

## Device Facts

- **Applicant:** Wako Chemicals USA, Inc.
- **Product Code:** [JIT](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIT.md)
- **Decision Date:** Apr 23, 2004
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.1150
- **Device Class:** Class 2
- **Review Panel:** Clinical Chemistry

## Indications for Use

The Wako Total Ketone Body Calibrators are intended to be used with the Wako Total Ketone Bodies and the Wako Autokit 3-HB test kits to establish points of reference that are used in the determination of values in the measurement of total ketone bodies and 3-HB in human serum or plasma. The calibrators are for Rx in vitro diagnostic use.

## Device Story

Wako Total Ketone Body Calibrators; liquid, ready-to-use calibrators; two levels (40 μmol/L and 300 μmol/L 3-Hydroxybutyrate). Used in clinical laboratory settings with Wako Total Ketone Bodies and Wako Autokit 3-HB test kits on Wako 30R® instruments. Provides reference points for assay calibration; enables accurate quantification of ketone bodies in patient serum or plasma. Value assignment derived via molar extinction coefficient (K-factor) of NADH.

## Clinical Evidence

No clinical data. Bench testing only. Real-time stability studies demonstrated that both calibrator levels remained within 1% of expected values over 15 months when stored at 10°C.

## Technological Characteristics

Liquid, ready-to-use calibrators. Matrix: Goods Buffer, polyethylene glycol, sodium azide, and 3-Hydroxybutyrate. Two levels: 40 μmol/L and 300 μmol/L. Traceability established via molar extinction coefficient (K-factor) of NADH.

## Regulatory Identification

A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)

## Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY DEVICE ONLY TEMPLATE

A. 510(k) Number:
k033860

B. Purpose of the Submission:
New device

C. Analyte:
Hydroxybutyric Acid

D. Type of Test:
Calibrator

E. Applicant:
Wako Chemicals, USA, Inc.

F. Proprietary and Established Names:
Wako Total Ketone Body Calibrators

G. Regulatory Information:
1. Regulation section:
21 CFR 862.1150, Calibrators, Secondary
2. Classification:
II
3. Product Code:
JIT
4. Panel:
Chemistry (75)

H. Intended Use:
1. Intended use(s):
Refer to Indications for use.
2. Indication(s) for use:
The Wako Total Ketone Body Calibrators are intended to be used with the Wako Total Ketone Bodies and the Wako Autokit 3-HB test kits to establish points of reference that are used in the determination of values in the measurement of total ketone bodies and 3-HB in human serum or plasma.

{1}

Page 2 of 3

(Reviewer Note: 3-HB is a common abbreviation for 3-Hydroxybutyrate.)

3. **Special condition for use statement(s):**
The calibrators are for Rx in vitro diagnostic use.

4. **Special instrument requirements:**
Wako 30R®

I. **Device Description:**
The products consist of two levels of liquid ready to use calibrators. They consist of a matrix of Goods Buffer, polyethylene glycol and sodium azide and are prepared by adding 3-Hydroxybutyrate.

J. **Substantial Equivalence Information:**

1. **Predicate device name(s):**
Stanbio Standard, 1 mM Sodium D-3-Hydroxybutyrate (Formerly GDS)

2. **Predicate K number(s):**
k910108

3. **Comparison with predicate:**
Both are liquid based calibrators intended to provide reference points for ketone assays. They are intended to calibrate different assays made by different manufacturers.

K. **Standard/Guidance Document Referenced (if applicable):**
The sponsor did not reference any standards in their submission.

L. **Test Principle:** Not applicable

M. **Performance Characteristics (if/when applicable):**

1. **Analytical performance:**

a. **Precision/Reproducibility:**
Not applicable.

b. **Linearity/assay reportable range:**
Not applicable.

c. **Traceability (controls, calibrators, or method):**

There are two levels of calibrators:
40 μmol/L and 300 μmol/L of 3-Hydroxybutyrate.

Calibrators are prepared by adding 3-Hydroxybutyrate to buffer.
The grade of chemicals utilized was not specified.

The value assignment and traceability is provided through use of the molar extinction coefficient (K-factor) of NADH.

{2}

Page 3 of 3

Results from Real Time Stability studies are summarized. The calibrators were evaluated for up to 15 months when stored at 10 degrees C and were both levels were within 1% of the expected value at all measurement times.

d. Detection limit: Not applicable.

e. Analytical specificity: Not applicable.

f. Assay cut-off: Not applicable.

2. Comparison studies:
a. Method comparison with predicate device: Not applicable.
b. Matrix comparison: Not applicable.

3. Clinical studies:
a. Clinical sensitivity: Not applicable. Clinical studies are not typically submitted for this device type.
b. Clinical specificity: Not applicable. Clinical studies are not typically submitted for this device type.
c. Other clinical supportive data (when a and b are not applicable):

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range: Not applicable.

N. Conclusion: The submitted information in this premarket notification is complete and supports a substantial equivalence decision.

---

**Source:** [https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIT/K033860](https://fda.innolitics.com/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JIT/K033860)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com